Pharmaceutical Product Development, Inc. · Wilmington, NC United States (NASDAQ: PPDI)
| 929 N. Front St. | Phone: 910-251-0081 |
| Wilmington, NC | Fax: 910-762-5820 |
| 28401 | |
| United States | 
Map This Company |
Pharmaceutical Product Development, Inc. Rankings
Company Description
Pharmaceutical Product Development (PPD) is on the hunt for newfangled drugs. One of the world's largest contract research organizations (CROs), PPD provides global research and development services to pharmaceutical, biotech, and medical device companies seeking regulatory approval for their products. The CRO offers a broad range of services, from toxicology testing in the earliest phases of drug research, to the management of large, multi-site clinical trials in which drug compounds are tested on human subjects. Its customers have included most of the world's top 50 pharma companies. PPD was acquired in 2011 for some $3.9 billion by private investors
Pharmaceutical Product Development, Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Private - NASDAQ: PPDI Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2010 Employees | 11,000 |
Executives
187 executives listed for Pharmaceutical Product Development, Inc.'s Wilmington, NC location.
| Chairman | Fredric Eshelman | |
|---|---|---|
| COO | William Sharbaugh | |
| CFO, Treasurer, and Assistant Secretary | Daniel Darazsdi |